BridgeMD
New treatment option for Postoperative Period
Official title Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection Surgery
ClinicalTrials.gov ID: NCT07001670
What this study is testing
- What it's testing
- This randomized controlled clinical trial aims to evaluate the effects of an 8-week tele-yoga intervention in individuals with lung cancer who have undergone lung resection surgery. The intervention group will receive supervised yoga sessions via online synchronous video conferencing, while the control group will continue with standard post-operative care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged between 18 and 65 years,
- Histologically confirmed diagnosis of Stage I-IIIA lung cancer according to the 9th edition of the AJCC Cancer Staging Manual,
- Underwent lobectomy, pneumonectomy, segmentectomy, or wedge resection via video-assisted thoracoscopic surgery (VATS) or robot-assisted thoracoscopic...
- An estimated life expectancy of ≥6 months,
- Karnofsky Performance Status score greater than 80% at study entry,
You likely can't join if
- History of receiving radiotherapy or chemotherapy prior to surgery,
- Presence of severe dysfunction in vital organs such as the heart, brain, kidneys, or others,
- Having any comorbid condition that contraindicates participation in an exercise training program,
- Presence of serious postoperative complications,
- Cognitive impairments that hinder effective communication,
- Current participation in a structured and regular exercise program,
See the full eligibility criteria
- Aged between 18 and 65 years,
- Histologically confirmed diagnosis of Stage I-IIIA lung cancer according to the 9th edition of the AJCC Cancer Staging Manual,
- Underwent lobectomy, pneumonectomy, segmentectomy, or wedge resection via video-assisted thoracoscopic surgery (VATS) or robot-assisted thoracoscopic surgery (RATS),
- An estimated life expectancy of ≥6 months,
- Karnofsky Performance Status score greater than 80% at study entry,
- Possession of the necessary equipment and access to a stable internet connection to enable participation in online interventions.
- History of receiving radiotherapy or chemotherapy prior to surgery,
- Presence of severe dysfunction in vital organs such as the heart, brain, kidneys, or others,
- Having any comorbid condition that contraindicates participation in an exercise training program,
- Presence of serious postoperative complications,
- Cognitive impairments that hinder effective communication,
- Current participation in a structured and regular exercise program,
- Missing three consecutive weeks of sessions or completing less than 75% of the prescribed exercises,
- Voluntary withdrawal from the study by the participant.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.